Donald I. Abrams
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 33
- HIV Research and Treatment 33
-
- Complementary and Alternative Medicine Studies 20
- Co-authors
- Starley B. ShadeMichael J. SilverbergMarcus A. ConantMichael E. KellyPaul A. VolberdingJames D. NeatonNeal L. BenowitzDeborah Greenspan
- Journals
- AIDS (13 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (8 papers)New England Journal of Medicine (6 papers)Clinical Infectious Diseases (5 papers)BMC Complementary and Alternative Medicine (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Donald I. Abrams
171 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Virology 2.2k
- Infectious Diseases 2.8k
- Pharmacology 1.9k
- Emergency Medicine 966
- Toxicology 239
Countries citing papers authored by Donald I. Abrams
This map shows the geographic impact of Donald I. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald I. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald I. Abrams more than expected).
Fields of papers citing papers by Donald I. Abrams
This network shows the impact of papers produced by Donald I. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald I. Abrams. The network helps show where Donald I. Abrams may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald I. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2019 | 11 | |
| 3 | 2018 | 13 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 7 | |
| 6 | 2014 | 4 | |
| 7 | 2014 | 1 | |
| 8 | 2013 | 23 | |
| 9 | 2013 | 32 | |
| 10 | 2013 | 58 | |
| 11 | 2012 | 115 | |
| 12 | 2011 | 202 | |
| 13 | 2007 | 17 | |
| 14 | 2006 | 17 | |
| 15 | 2000 | 75 | |
| 16 | 1999 | 1 | |
| 17 | 1998 | 58 | |
| 18 | 1996 | 43 | |
| 19 | Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS. | 1995 | 7 |
| 20 | 1994 | 1 |
About Donald I. Abrams
Donald I. Abrams is a scholar working on Virology, Complementary and alternative medicine, Infectious Diseases, Emergency Medicine and Pharmacology, having authored 178 papers that have together received 9.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (33 papers), HIV/AIDS Research and Interventions (32 papers), Cannabis and Cannabinoid Research (31 papers), Viral-associated cancers and disorders (29 papers), HIV/AIDS drug development and treatment (23 papers), Complementary and Alternative Medicine Studies (20 papers), HIV-related health complications and treatments (19 papers) and Lymphoma Diagnosis and Treatment (19 papers). The work is most often cited by research in Virology (2.2k citations), Infectious Diseases (2.8k citations), Pharmacology (1.9k citations), Emergency Medicine (966 citations) and Toxicology (239 citations). Donald I. Abrams has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Starley B. Shade, Michael J. Silverberg, Marcus A. Conant, Michael E. Kelly, Paul A. Volberding, James D. Neaton, Neal L. Benowitz, Deborah Greenspan, Evelyne T. Lennette and John S. Greenspan. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, New England Journal of Medicine, Clinical Infectious Diseases and BMC Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.